Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-(2-fluorophenoxy)-5-nitropyridine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

218795-32-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 218795-32-5 Structure
  • Basic information

    1. Product Name: 2-(2-fluorophenoxy)-5-nitropyridine
    2. Synonyms: 2-(2-fluorophenoxy)-5-nitropyridine
    3. CAS NO:218795-32-5
    4. Molecular Formula: C11H7FN2O3
    5. Molecular Weight: 234.18
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 218795-32-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 2-(2-fluorophenoxy)-5-nitropyridine(CAS DataBase Reference)
    10. NIST Chemistry Reference: 2-(2-fluorophenoxy)-5-nitropyridine(218795-32-5)
    11. EPA Substance Registry System: 2-(2-fluorophenoxy)-5-nitropyridine(218795-32-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 218795-32-5(Hazardous Substances Data)

218795-32-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 218795-32-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,8,7,9 and 5 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 218795-32:
(8*2)+(7*1)+(6*8)+(5*7)+(4*9)+(3*5)+(2*3)+(1*2)=165
165 % 10 = 5
So 218795-32-5 is a valid CAS Registry Number.

218795-32-5Downstream Products

218795-32-5Relevant articles and documents

HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF EPILEPSY

-

Paragraph 0134; 0143; 0144, (2020/06/19)

The present invention provides a novel heterocyclic compound represented by Formula [I] and a salt thereof: wherein the symbols are as defined in the specification, which is useful for treating, preventing and/or diagnosing seizure and the like in disease involving epileptic seizure or convulsive seizure (including multiple drug resistant seizure, refractory seizure, acute symptomatic seizure, febrile seizure and status epilepticus), as well as a medical use therefor.

5-SUBSTITUTED INDAZOLE-3-CARBOXAMIDES AND PREPARATION AND USE THEREOF

-

Paragraph 1308; 1309, (2015/11/09)

Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of an indazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, Alzheimer's disease, lung disease, fibrotic disorders, cartilage (chondral) defects, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, and neurological conditions/disorders/diseases linked to overexpression of DYRK1A.

INHIBITORS OF BRUTON'S TYROSINE KINASE

-

Page/Page column 59; 63; 78; 79, (2015/06/25)

This application discloses compounds according to generic Formula (I) wherein all variables are defined as described herein, which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with ex

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 218795-32-5